A testosterone-containing nasal spray received its second U.S. patent and its first patent in Europe, making it the first testosterone therapy licensed to treat anxiety disorders. Although testosterone therapy is most often marketed and prescribed to men suffering from “low…
Read MoreAnti-COVID-19 nasal spray ‘ready for use in humans’
A nasal spray that can provide effective protection against the COVID-19 virus has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans. A team in the university’s Healthcare Technologies Institute formulated the…
Read More